A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
暂无分享，去创建一个
J. Pichler | W. Mason | A. Brandes | G. Finocchiaro | M. Makrutzki | V. Zagonel | R. Anghel | G. Fountzilas | F. Ghiringhelli | F. Saran | M. Gil-Gil | A. Carpentier | D. Cernea | A. Nowak | E. Franceschi | C. Mpofu | G. Lombardi | O. Chinot | F. Dubois | P. Beauchesne | Hans-Joerg Urban